Back to CLDX

Kynam Capital Management, LP → CLDX

Kynam Capital Management, LP CLDX Position History

Celldex Therapeutics, Inc.

Quarters held
4
Latest value
$164.2M
Q3 2026
Peak value
$198.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$161.4M
Q1 2026$185.3M
Q2 2026$198.1M
Q3 2026$164.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$164.2M5.07M——
Q2 2026$198.1M5.32M——
Q1 2026$185.3M5.84M——
Q4 2025$161.4M5.94M——

Other funds holding CLDX

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M
PCVX

VAXCYTE INC

$169.8M
SNDX

SYNDAX PHARMACEUTICALS INC

$169.2M